http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2058142-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e35032057b63fd22eb26fc44d47ed22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4123ce7303db6b5abb72c57704140e2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bda0f8ef207d05bab322f9320325910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af4012bc3f45c833805784033ba4dc27
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 1991-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_575ae1db60a9c8a41a7fb7d8efdfdbb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853b05d3d0d2bca2932a292080b66565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e9b944eeaf323709ac28d8ae4812b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750c1c976b0dee4a64f0878e67429d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70a49798589443a42d846ee903e57e5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb5e00f203ab8d6fd375953a5778036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46c2dba5b3393c0a810ce2dc3c98f2f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c05aa23219c97c5a99160985f558031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_661e73ad401a06f71124c60fa89f3718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b832afa7eacb8849cb0514bf913a9e1
publicationDate 1996-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2058142-C1
titleOfInvention Agent showing antisecretory and antiulcer activity
abstract FIELD: medicine. SUBSTANCE: the use of 9-diethylaminoethyl-2-phenylimidazo-[1,2-a]-benzimidazole nitrate exhibits an expressed inhibiting effect on hydrochloric acid and pepsin secretion that is accompanied with significant antiulcer action. At 7 hr pylorus ligation activity of proposed agent is 46 and 28.4-fold as compared with that for cimetidine and omeprazole, respectively, and by therapeutic index - by 10.5 and 55-fold, respectively. Agent decreases ulcer formation in stomach mucosa, and antiulcer effect of agent is enhanced. EFFECT: enhanced effectiveness of agent proposed. 2 dwg, 10 tbl
priorityDate 1991-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00793
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54300780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416224283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409552283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID887
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055003
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28713
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15326335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1712095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422755685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450354217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553297
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100685087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416101654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535044
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423475041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393347
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27822
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13776
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N2D4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID914517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2520

Total number of triples: 84.